User profiles for Shermarke Hassan

Shermarke Hassan

PhD student, Leiden University Medical Center
Verified email at lumc.nl
Cited by 204

[HTML][HTML] Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001–2018

S Hassan, RC Monahan… - Journal of Thrombosis …, 2021 - Elsevier
Background Treatment of patients with hemophilia has advanced over the past decades,
but it is unknown whether this has resulted in a normal life expectancy in the Netherlands. …

[HTML][HTML] Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972–2019

S Hassan, EC van Balen, C Smit… - Journal of Thrombosis …, 2021 - Elsevier
Introduction We conducted six cross‐sectional nationwide questionnaire studies among all
patients with hemophilia in the Netherlands from 1972 until 2019 to assess how health …

[HTML][HTML] Validation of PROMIS Profile‐29 in adults with hemophilia in the Netherlands

EC van Balen, L Haverman, S Hassan, EM Taal… - Journal of Thrombosis …, 2021 - Elsevier
Background The Patient‐Reported Outcomes Measurement Information System (PROMIS)
Profile‐29 questionnaire is widely used worldwide, but it has not yet been validated in the …

[HTML][HTML] Factor VIII products and inhibitor development in previously treated patients with severe or moderately severe hemophilia A: a systematic review

S Hassan, A Cannavò, SC Gouw, FR Rosendaal… - Journal of Thrombosis …, 2018 - Elsevier
Essentials • Data on product‐related immunogenicity in previously treated haemophilia A
patients is scarce. • A systematic review and meta‐analysis of all currently available evidence …

Similar sports participation as the general population in Dutch persons with haemophilia; results from a nationwide study

O Versloot, EC van Balen, S Hassan, SEM Schols… - …, 2021 - Wiley Online Library
Introduction Although sports participation is advocated in people with haemophilia (PWH),
detailed data concerning sports participation in Dutch PWH is lacking. Aim to assess sports …

[HTML][HTML] Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study

EC van Balen, S Hassan, C Smit… - Research and practice …, 2022 - Elsevier
Background and objectives Treatment availability and comprehensive care have resulted in
improved clinical outcomes for persons with hemophilia. Recent data on socioeconomic …

Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET Cohort

S Hassan, G Baselli, L Mollica, RL Rossi… - Blood …, 2024 - ashpublications.org
Inhibitor development is the most severe complication of hemophilia A care, and is associated
with increased morbidity and mortality. The aim of this study was to use a novel IgG …

The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A

…, JCJ Eikenboom, K Fijnvandraat, S Hassan… - Frontiers in …, 2024 - frontiersin.org
Objectives Anti-factor VIII (FVIII) antibodies have been reported to exhibit both neutralizing
and non-neutralizing characteristics. This is the first study investigating the full spectrum of …

The usefulness of D-dimer as a predictive marker for mortality in patients with COVID-19 hospitalized during the first wave in Italy

S Hassan, B Ferrari, R Rossio, V la Mura, A Artoni… - Plos one, 2022 - journals.plos.org
Background The coronavirus disease 2019 (COVID-19) presents an urgent threat to global
health. Identification of predictors of poor outcomes will assist medical staff in treatment and …

External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019

S Hassan, CL Ramspek, B Ferrari… - European Journal of …, 2022 - Elsevier
Background The coronavirus disease 2019 (COVID-19) presents an urgent threat to global
health. Prediction models that accurately estimate mortality risk in hospitalized patients could …